P896-0526 Screening compound: ethyl 4-{2-ethyl-1-oxo-1H,2H,3H,4H,5H-pyrrolo[1,2-a][1,4]diazepine-8-sulfonamido}benzoate

P896-0526 Screening compound: ethyl 4-{2-ethyl-1-oxo-1H,2H,3H,4H,5H-pyrrolo[1,2-a][1,4]diazepine-8-sulfonamido}benzoate
P896-0526 Screening compound: ethyl 4-{2-ethyl-1-oxo-1H,2H,3H,4H,5H-pyrrolo[1,2-a][1,4]diazepine-8-sulfonamido}benzoate alternative view

Chemical Structure Depiction of ChemDiv screening compound P896-0526
ethyl 4-{2-ethyl-1-oxo-1H,2H,3H,4H,5H-pyrrolo[1,2-a][1,4]diazepine-8-sulfonamido}benzoate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P896-0526

Molecular Formula

C19H23N3O5S (C19 H23 N3 O5 S)

Compound Name

ethyl 4-{2-ethyl-1-oxo-1H,2H,3H,4H,5H-pyrrolo[1,2-a][1,4]diazepine-8-sulfonamido}benzoate

IUPAC name

ethyl 4-{2-ethyl-1-oxo-1H2H3H4H5H-pyrrolo[12-a][14]diazepine-8-sulfonamido}benzoate

SMILES

CCN(CCCn1c2cc(S(Nc(cc3)ccc3C(OCC)=O)(=O)=O)c1)C2=O

InChI

InChI=1S/C19H23N3O5S/c1-3-21-10-5-11-22-13-16(12-17(22)18(21)23)28(25,26)20-15-8-6-14(7-9-15)19(24)27-4-2/h6-9,12-13,20H,3-5,10-11H2,1-2H3

InChI Key

SWAUPLROVWDEPX-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD29027205

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

405.47

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.522

Distribution Coefficient, logD

2.459

Water Solubility, LogSw

-2.89

Polar Surface Area

80.709

Acid Dissociation Constant (pKa)

8.21

Base Dissociation Constant (pKb)

-1.93

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

36.80

P896-0526 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

SH2 Library (10483 compounds)

SmartTM Library (51161 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Endocrine
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with P896-0526 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P896-0526?
Check Price and Availability of P896-0526, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P896-0526 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P896-0526
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P896-0526
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P896-0526 available by request